Pharma News

Pharma Courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • PharmaTutor
    29 March 2010

    Centre approves establishment of Indo-German Science & Technology Centre in India

    The central government has approved the establishment of Indo-German Science and Technology Centre (IGSTC) in India with matching contribution as per Expenditure Finance Committee (EFC) approval of 2 million Euro (approximately Rs 13 crore at current exchange rates) per year for next five years. The Centre would be registered as a “Society” under the relevant Act.

  • 27 March 2010
    Antithrombotic Therapy Does Not Improve Outcomes in Recurrent Miscarriage

     In women with 2 or more unexplained miscarriages, aspirin therapy alone or in combination with the low-molecular-weight heparin derivative nadroparin does not increase the live-birth rate, relative to placebo, despite its widespread use for this purpose.

    That is according to the randomized placebo-controlled Anticoagulants for Living Fetuses (ALIFE) study, published online March 24 in the New England Journal of Medicine.

  • 27 March 2010
    TN govt to enforce D&C Act, Rules strictly in state: Health secretary

     In the wake of the recent unearthing of major illegal trade practices including recycling of expired drugs by certain pharmaceutical traders in Chennai, the Health Department of Tamil Nadu Government has decided to enforce the Drugs & Cosmetics Act and Rules strictly in the state.

  • 27 March 2010
    Poniard Pharma suspends efforts to obtain regulatory approval for picoplatin in SCLC

     Poniard Pharmaceuticals, Inc., a biopharmaceutical company focused on innovative oncology therapies, announced a clinical and regulatory update on its lead product candidate, picoplatin. Following a detailed analysis of primary and updated data from the phase 3 SPEAR study of picoplatin in small cell lung cancer (SCLC) and an evaluation of the ongoing New Drug Application (NDA) process with the US Food and Drug Administration (FDA), the company has decided to suspend its efforts to obtain regulatory approval for picoplatin in SCLC at this time.

  • 25 March 2010
    NIH creates new genetic testing registry to help researchers, consumers & healthcare providers

     The National Institutes of Health (NIH) announced that it is creating a public database that researchers, consumers, health care providers, and others can search for information submitted voluntarily by genetic test providers. The Genetic Testing Registry (GTR) aims to enhance access to information about the availability, validity, and usefulness of genetic tests.

  • 25 March 2010
    Two-day 'CLINICON 2010' to be held in Bangalore from March 26

    A two-day symposium on clinical trial 'CLINICON 2010' will be held at Narayana Health City in Bangalore from March 26 to 27, 2010. The event will help bring together experts in the field of clinical research.

  • 25 March 2010
    Third national IPA Convention to be held in Indore in April, 2011

     The next Indian Pharmaceutical Association Convention (IPA Convention 2011) will be held at Indore in Madhya Pradesh in April next year. This was announced by the outgoing president of IPA Dr B Suresh at the valedictory session of the IPA Convention 2010 held in Chennai last week.

  • 25 March 2010
    PCI clarifies its notification on MS not specific on NIPER's course

     Entailing the ongoing controversy over the recognition of Master of Pharmacy (MS) programme offered by National Institute of Pharmaceutical Education and Research (NIPER), Mohali, Pharmacy Council of India (PCI) has come out with a clarification that the NIPER's MS programme has not been specifically commented anytime by the council and is not an issue under the consideration of the body.

  • 24 March 2010
    Women With MI Less Likely to Get Cath Procedures

     March 23, 2010 (Atlanta, Georgia) — An unexplained bias against sending women to the cath lab may be the reason women are about twice as likely as men to die within a month of an MI, a study from the European Cardiology Audit and Registration Data Standards (CARDS) data set shows.

  • 24 March 2010
    Piramal Healthcare acquires i-pill brand from Cipla

     Piramal Healthcare and Cipla signed a definitive agreement for purchase of all intellectual property rights in India related to i-pill brand of Cipla. The deal was sealed for an aggregate consideration of Rs 95 crore. i-pill brand features in the top-300 pharmaceutical products and had sales of Rs 30.92 crore as per ORG IMS for the last twelve months.

Subscribe to Pharma News